WINDLASWindlas Biotech Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹871.55
▲ 3.23%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,756.20
P/E27.35
P/B3.34
PEG—
ROE %12.23
ROCE %12.00
Debt / Equity0.06
EPS31.12
Revenue Growth %17.70
Profit Growth %-2.60
Dividend Yield %1.44
Promoter Holding %65.75
FII Holding %9.56
DII Holding %—
Beta0.27
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 73% | ₹871.55 | ₹819.81 | ₹947.54 | 1.47 |
HOLDConviction 72%
The picture
- • Revenue growth: 17.7% YoY
- • Debt/Equity: 0.06
- • Promoter holding: 65.8%
- • RSI: 60
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
- • Pullback to 21-EMA signal (setup quality 73%)
Bull case
- • Revenue growth: 17.7% YoY
- • Debt/Equity: 0.06
- • Promoter holding: 65.8%
- • RSI: 60
Bear case
- • Profit growth: -2.6% YoY
- • 3-month return: -1.4%
- • Max drawdown (1y): 34%
Key risks
- • Profit growth: -2.6% YoY
- • 3-month return: -1.4%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹871.55
Stop Loss
₹808.66
risk 7.2%
Target 1 (1.5R)
₹965.88
+10.8%
Target 2 (3R)
₹1,060.22
+21.6%
Support (20d)
₹816.83
Resistance (52w)
₹1,097.90
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹62.89/share
ATR (volatility)
₹28.06
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹28.06). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
61
Technical
81
Momentum
59
Risk (safety)
57